Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
171.68B
Market cap171.68B
Price-Earnings ratio
11.07
Price-Earnings ratio11.07
Dividend yield
3.19%
Dividend yield3.19%
Average volume
19.63M
Average volume19.63M
High today
$38.60
High today$38.60
Low today
$37.79
Low today$37.79
Open price
$37.97
Open price$37.97
Volume
11.44M
Volume11.44M
52 Week high
$82.57
52 Week high$82.57
52 Week low
$35.85
52 Week low$35.85

NVO News

Nasdaq 20h
Why the Novo Nordisk and Hims & Hers Deal Is a Win for Both Stocks

Key Points Novo Nordisk is dropping its lawsuit against Hims & Hers Health, as it has reached an agreement with the telehealth company. The deal will permit H...

Why the Novo Nordisk and Hims & Hers Deal Is a Win for Both Stocks
Simply Wall St 1d
Hims & Hers Health Is Up 57.4% After Renewed Novo Nordisk GLP-1 Partnership - Has The Bull Case Changed?

Earlier this month, Hims & Hers Health, Inc. resolved its legal dispute with Novo Nordisk and entered a renewed collaboration in which Novo Nordisk will supply...

Hims & Hers Health Is Up 57.4% After Renewed Novo Nordisk GLP-1 Partnership - Has The Bull Case Changed?
Simply Wall St 2d
Novo Nordisk Telehealth Deal Weighs On Weak Share Price And Valuation

Novo Nordisk and Hims & Hers have resolved their legal dispute and entered into a new distribution partnership. Hims & Hers will move patients from compounded...

Novo Nordisk Telehealth Deal Weighs On Weak Share Price And Valuation

Analyst ratings

61%

of 33 ratings
Buy
33.3%
Hold
60.6%
Sell
6.1%

More NVO News

The Motley Fool 3d
Is Eli Lilly's Weight Loss Empire in Trouble?

Over the past two years, Eli Lilly (LLY +0.80%) has established itself as the leader in the weight loss market. That's thanks to the company's tirzepatide, a co...

Is Eli Lilly's Weight Loss Empire in Trouble?
The Motley Fool 5d
Stock Market Today, March 12: Hims and Hers Health Drops After Rally Sparks Profit Taking

Expand NYSE : HIMS Hims & Hers Health Today's Change ( -7.88 %) $ -2.04 Current Price $ 23.84 Key Data Points Market Cap $5.9B Day's Range $ 23.76 - $ 27.24 52w...

Stock Market Today, March 12: Hims and Hers Health Drops After Rally Sparks Profit Taking
Simply Wall St 5d
Hims And Hers Benefits Aims To Deepen Member Loyalty And Engagement

Hims & Hers Health (NYSE:HIMS) launched the Hims & Hers Benefits program, expanding its subscription platform beyond prescriptions. The program gives subscribe...

Hims And Hers Benefits Aims To Deepen Member Loyalty And Engagement
TipRanks 5d
Novo Nordisk price target lowered to DKK 300 from DKK 360 at Berenberg

Berenberg analyst Kerry Holford lowered the firm’s price target on Novo Nordisk (NVO) to DKK 300 from DKK 360 and keeps a Buy rating on the shares. Published f...

TipRanks 5d
Novo Nordisk’s AMAZE 8 Trial: A New Phase 3 Bet in Obesity and Diabetes

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Novo Nordisk (NVO) has launched AMAZE 8, a Phase 3 study testing its new weekly shot NN...

TipRanks 5d
Novo Nordisk Maps Global Awareness of Metabolic Liver Disease With ACT on MASH Study

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Novo Nordisk Probes Global Awareness Gaps in Liver Disease Risk The ACT on MASH study...

24/7 Wall St. 5d
Is Hims & Hers Really the Growth Stock to Buy That It Appears?

Is Hims & Hers Really the Growth Stock to Buy That It Appears? Quick Read Hims & Hers (HIMS) agreed to sell branded Wegovy and Ozempic directly on its platform...

Is Hims & Hers Really the Growth Stock to Buy That It Appears?

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.